OTC · BDRFY
Consumer Defensive · Household & Personal Products
$19.29
Up+$0.80 (+4.32%)
Updated Nov 5, 2026, 2:30 AM
SID Score
5.0/10
Composite research score
Smart Money
46/100
Neutral
Price performance · BDRFY
1M range · 0 trading sessions · Daily adjusted prices
BDRFY does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning BDRFY.
Company
Market Activity
Research & News
BDRFY research
Company profile and research snapshot.
BEIERDORF AG UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
| Sep 23, 2026 | LANDESBANK BADEN-WUERTTEMBERG | Buy | — |
| Aug 31, 2026 | BNP PARIBAS | Neutral | — |
| Aug 28, 2026 | METZLER EQUITIES | Hold | — |
| Aug 26, 2026 | BERENBERG | Hold | — |
No generated briefing is available yet.
seekingalpha.com · Oct 25, 2025
Beiersdorf is upgraded to 'Buy' as the stock's recent decline offers ~30% upside to a $138 price target. BDRFF's Q3 FY 2025 results beat expectations, with strong growth in Eucerin and La Prairie brands, despite Nivea's recent softness. Key catalysts include Nivea's Epicelline launch, La Prairie's India entry, and Eucerin's expansion into Japan, positioning for a rebound.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BDRFY.
No results
No recent SID articles mention BDRFY.
